Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett Syndrome ...Middle East

Initiation of global clinical development program for RVL-001 in Rett syndrome underway, with recently announced Rett studies in the US led by Vanderbilt and in Colombia led by Unravel. BOSTON, May 28, 2024 /PRNewswire/ -- Unravel Biosciences, Inc., ("Unravel"), an AI-enabled therapeutics...

Hence then, the article about unravel biosciences receives fda orphan drug designation for vorinostat rvl 001 as a treatment for rett syndrome was published today ( Tuesday 28/05/2024 - 06:25 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett Syndrome )

Also on site :

• Cruise ship boss sues P&O for massive £9.7m over claims slip in toilet ended career
• Trump’s letter to Norway proves it: he’s lost his mind over the Nobel Peace Prize
• Michael Kors Outlet Has a 'Roomy' Shoulder Bag That Oozes Style on Sale for Just $76